Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study by Marco Budeus, Marcus Hennersdorf, Stefan Perings, Shinga Röhlen, Stefan Schnitzler, Oliver Felix, Klaus Reimert, Peter Feindt, Emmeran Gams, Nils Lehmann, Heinrich Wieneke, Stefan Sack, Raimund Erbel, and Christian Perings EHJ Volume 27(13): June 19, 2006 © The European Society of Cardiology All rights reserved. For Permissions, please
Flow diagram of the study. Marco Budeus et al. Eur Heart J 2006;27: © The European Society of Cardiology All rights reserved. For Permissions, please
Kaplan–Meier analysis of percentages of patients remaining free from AF after CABG. Triangles, patients with amiodarone; circles, patients with placebo. Marco Budeus et al. Eur Heart J 2006;27: © The European Society of Cardiology All rights reserved. For Permissions, please
Kaplan–Meier analysis of percentages of patients treated with amiodarone remaining free from AF after CABG depending on amiodarone concentration. Marco Budeus et al. Eur Heart J 2006;27: © The European Society of Cardiology All rights reserved. For Permissions, please